Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × NETWORK × pembrolizumab × Clear all

Phase

Phase 2 6 Phase 3 4 Phase 2/3 3 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

INDUSTRY 202 OTHER 123 NIH 7 OTHER_GOV 2 NETWORK 1 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 1 Breast Neoplasms 1

Interventions

Radiotherapy 11 Cisplatin 7 Cytarabine 6 Specimen Handling 4 Paclitaxel 4 Lapatinib 4 Fluorouracil 4 Docetaxel 4 Brachytherapy 4 Temozolomide 3 Radiotherapy, Conformal 3 Methotrexate 3 Irinotecan 3 Gemcitabine 3 Dexamethasone 3 Carboplatin 3 Biopsy 3 venetoclax 2 pomalidomide 2 neratinib 2 carfilzomib 2 Radiation 2 Polymerase Chain Reaction 2 Oxaliplatin 2 Leucovorin 2 Immunohistochemistry 2 Idarubicin 2 Etoposide 2 Clofarabine 2 Carmustine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02129556 2019-02-15

PANACEA

ETOP IBCSG Partners Foundation

Phase 1/2 Completed

58 enrolled 16 charts

Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡